Hepatocellular carcinoma
Conditions
Interventions
Experimental group:TACE+PVE+Hepatectomy
Sponsors
the Third Affiliated Hospital, Naval Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 70 years old; 2. Clinical diagnosis of hepatocellular carcinoma (clinical diagnosis criteria for hepatocellular carcinoma: meet the 2024 Guidelines for Primary liver Cancer Diagnosis and Treatment or 2022 Barcelona stage) : a) Stage Ib or IIa of CNLC or stage A or B1 of BCLC with a single tumor diameter greater than 5cm or = 100*10^9/L, HBV-DNA 10^3; 10. Sign informed consent;
Exclusion criteria
Exclusion criteria: 1. Tumor types other than the inclusion criteria; 2. Have a history of other tumors; 3. Serious concomitant diseases (cardiovascular and cerebrovascular diseases, etc.); 4. Cirrhosis with esophageal varicose veins; 5. Platelet < 100*10^9/L;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| median progression free survival, mPFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| median overall survival, mOS;MVI positive rate;Tumor necrosis rate;Complication rate; | — |
Countries
China
Contacts
Public ContactZHOU Weiping, NI Junsheng
Eastern Hepatobiliary Surgery Hospital, the Third Affiliated Hospital of Naval Medical University
Outcome results
None listed